Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rate control therapy evaluation in atrial fibrillation
ISRCTN95259705Phase 4Completed
- Sponsor
- University of Birmingham
- Start
- Dec 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 4, randomised, open-label trial in Atrial fibrillation (AFib) comparing Digoxin strategy with Bisoprolol strategy (2 arms). Primary endpoint: SF-36 physical component summary score at 6 months. Started Dec 2016; status: completed.
02
Drugs
digoxinbisoprolol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on ISRCTN95259705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN95259705.